期刊文献+

南风Ⅰ号治疗化疗药物外渗致组织损伤的临床研究 被引量:6

Clinical Research on NanfengⅠin the Treatment of the Injury Caused by Chemotherapeutic Extravasation
下载PDF
导出
摘要 目的探讨化疗药物外渗致组织损伤的治疗方法。方法将50例住院肿瘤患者随机分为南风Ⅰ号组(20例)、喜疗妥组(15例)和如意金黄散组(15例),各组采用上述不同药物治疗。南风Ⅰ号主要由紫草、丹参、大黄、蜂房炭、冰片等按比例组成;喜疗妥、如意金黄散采用市售成药,3组均外敷损伤部位。结果治疗14d,南风Ⅰ号组疗效显著优于如意金黄散组(P<0.01)。南风Ⅰ号组、喜疗妥组、如意金黄散组治疗7d后显效病例中红肿消退时间分别为(4.4±1.5)d、(5.3±1.2)d和(5.5±1.3)d。结论南风Ⅰ号具有明显促进化疗药物外渗损伤修复的作用。 Objective To investigate the treatment options for the injury caused by chemotherapeutics extravasation. Methods Fifty patients were randomly divided into three groups: Nanfeng Ⅰ group (n = 20), Hirudoid group (n = 15) and Ruyijinhuangsan powder group(n= 15). Nanfeng Ⅰ was the target medicine in this research, and its major ingredients include Arnebia Root, Danshen Root, Chinese rhubarb, beehive charcoal, Borneol etc. Hirudoid and Ruyijinhuangsan were commercially available patent medicines. The medicines were applied to the injured area respectively. Results Compared with the Ruyijinhuangsan, Nanfeng Ⅰ had much better effect on day 14 (P〈0.01). After treatment for 7 days, the time of disappearance of redness and swelling was (4.4±1.5)d,(5.3±1.2) d and (5.5±1.3) d. Conclusion The Nanfeng Ⅰ can repair the injury caused by chemotherapeutics extravasation.
出处 《护理学杂志》 2005年第20期46-48,共3页
基金 江苏省南通市卫生局基金资助(通卫规财[2004]39号W0431)
关键词 南风Ⅰ号 植物 药用 肿瘤 化疗 血管渗漏 Nanfeng Ⅰ traditional Chinese medicine tumor chernotherapeutics extravasation extravascular exudation
  • 相关文献

参考文献5

二级参考文献28

  • 1李海燕,张兰凤,孟凡迅,施耀成,段文娟,高媛媛.单味中药拮抗长春瑞宾外渗损伤的实验研究[J].肿瘤学杂志,2005,11(2):139-140. 被引量:3
  • 2王光华,陈梅,张小谦,陈锦辉,杨善民,陈福.丝裂霉素C血管外漏致皮肤溃疡的防护实验[J].中华护理杂志,1995,30(2):67-70. 被引量:29
  • 3黄红艳,杨云芬.静脉输注化疗药物对血管组织的损伤[J].实用护理杂志,1996,12(1):42-43. 被引量:122
  • 4黄春英.654-2治疗静脉炎及渗漏性损伤[J].护士进修杂志,1996,11(3):39-39. 被引量:51
  • 5林菊英 金乔.中华护理全书[M].南昌:江西科学技术出版社,1996.25.
  • 6周莲 姜明杰.高渗糖联合硫酸镁和维生素B12用于化疗药渗漏处皮肤[J].中华护理杂志,2000,35(2):119-119.
  • 7Berghammer P,P(o)hnl R,Baur M.Docetaxel extravasation[J].Support Care Cancer,2001,9(2):131-134.
  • 8Langer SW,Sehested M ,Jensen PB .Dexrazoxane is a potent and specific inhibitor of anthracyline induced subcutaneous lesions in mice[J].Ann Oncol,2001,12(3):405-410.
  • 9Disa JJ,Chang RR,Mucci SJ.Prevention of adriamycin-induced full-thickness skinloss using hyaluronidase infiltration[J].Plastic Reconstr Surg,1998,101(2):370-374.
  • 10Aktas S,Toklu AS,Olgac V.Hyperbaric oxygen therapy in adriamycin extravasation:an experimental animal study[J].Ann Plast Surg,2000,45(2):167-171.

共引文献42

同被引文献47

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部